Pulmonary involvement in systemic scleroderma;Les atteintes pulmonaires de la sclérodermie

Bulletin de l'Academie Nationale de Medecine

Volumn 195, Issue 1, 2011, Pages 79-92

  Guillevin, Loïc ^a   Mouthon, Luc ^a  

^a Institut Cochin   (France)

Author keywords

Hypertension; Pulmonary fibrosis; Scleroderma; Systmic

Indexed keywords

ARTICLE; HUMAN; LUNG FIBROSIS; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS;

HUMANS; HYPERTENSION, PULMONARY; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC;

EID: 80052826986     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Society International Multidisciplinary ConsensusClassification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med., 2002,165, 277-304.
2. TAMBY M.C., CHANSEAUD Y., GUILLEVIN L., MOUTHON L. - New insights into the pathogenesis of systemic sclerosis. Autoimmun Rev., 2003,2, 152-7. (Pubitemid 37443852)
3. BUOMMINO E., FARZATI A. et al. - Peripheral blood T lymphocytes from systemic sclerosis patients show both Thl and Th2 activation. J. Clin. Immunol., 2001,21, 210-7. (Pubitemid 32434308)
4. MOUTHON L., BEREZNE A., BRAUNER M., KAMBOUCHNER M., GUILLEVIN L., VALEYRE D. - Pneumopathie infiltrante diffuse de la sclerodermic systemique. Presse Med., 2006,35, 1943-51. (Pubitemid 44915266)
5. ALLANORE Y., BORDERIE D., LEMARECHAL H., EKINDJIAN O.G., KAHAN A. - Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis. Am. J. Med., 2004,116, 595-600. (Pubitemid 38490533)
6. WELLS A.U., CULLINAN P., HANSELL D.M., RUBENS M.B., BLACK CM., NEWMAN-TAYLOR A.J. et al. - Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am. J. Respir. Crit. Care Med., 1994,149, 1583-90. (Pubitemid 24175979)
7. SCUSSEL-LONZETTI L., JOYAL F., RAYNAULD J.P., ROUSSIN A., RICH E., GOULET J.R. et al. - Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine. 2002, 81, 154-67. (Pubitemid 34218570)
8. STEEN V.D., MEDSGER T.A. JR. - Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum., 2000,43, 2437-44.
9. MASI A.T., RODNAN G.P., MEDSGER T.A., ALTMAN R., D'ANGELO W., FRIES J. et al. - Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthr. Rheum., 1980,25,581-90. (Pubitemid 10101764)
10. STEEN V.D., CONTE C, OWENS G.R., MEDSGER T.A. - Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum., 1994,57, 1283-9. (Pubitemid 24320744)
11. DESAI S.R., VEERARAGHAVAN S., HANSELL D.M., NIKOLAKOPOLOU A., GOH N.S., NICHOLSON A.G. et al. - CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology. 2004, 232, 560-7. (Pubitemid 38971300)
12. BOUROS D., WELLS A.U., NICHOLSON A.G., COLBY T.V., POLYCHRONOPOULOS V., PANTELIDIS P. et al. - Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their Relationship to outcome. Am. J. Respir. Crit. Care Med., 2002,165, 1581-6. (Pubitemid 34693935)
13. GALIE N., HOEOER M.M., HUMBERT M., TORBICKI A., VACHIERY J.L., BARBERA J.A., BEGHETTI M., CORRIS P., GAINE S., GIBBS J.S., GOMEZ-SANCHEZ M.A., JONDEAU G., KLEPETKO W., OPITZ C, PEACOCK A., RUBIN L., ZELLWEGER M., SIMONNEAU G. - ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur. Heart J., 2009, 30, 2493-537.
14. HIMBERT M., SITBON O., CHAOUAT A., BERTOCCHI M., HABIB G., GRESSIN V., YAICI A., WEITZENBLUM E., CORDIER J.F., CHABOT F. et al. - Pulmonary arterial hypertension in France: results from a national registry. Am. J. Respir. Crit. Care Med., 2006,173, 1023-1030.
15. HACHULLA E., GRESSIN V., GUILLEVIN L., CARPENTER P., DIOT E., SIBILIA J., KAHAN A., CABANE J., FRANCES G, LAUNAY D. et al. - Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum., 2005, 52, 3792-3800. (Pubitemid 41798217)
16. MOUTHON L., GUILLEVIN L., HUMBERT M. - Pulmonary arterial hypertension: an autoimmune disease? Eur. Respir. J., 2005,26(6), 986-8. (Pubitemid 41829926)
17. LAUNAY D., HUMBERT M., HACHULLA E. - L'hypertension arterielle pulmonaire de la sclerodermic systemique. Presse Med., 2006, 35(12 Pt 2)1929-37. (Pubitemid 44915264)
18. FAGAN K.A., BADESCH D.B. - Pulmonary hypertension associated with connective tissue disease. Prog. Cardiovasc Dis., 2002 Nov-Dec., 45(3), 225-34. (Pubitemid 36139818)
19. WHITE B., MOORE W.C., WIGLEY F.M., XIAO H.Q., WISE R.A. - Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann. Intern. Med., 2000,132, 947-54. (Pubitemid 30397594)
20. TASHKIN D.P., ELASHOFF R., CLEMENTS P.J., GOLDIN J., ROTH M.D., FURST D.E. et al. - Cyclophosphamide versus placebo in scleroderma lung disease. N. Engl. J. Med., 2006, 354, 2655-66.
21. BEREZNE A., RANQUE B., VALEYRE D., BRAUNER M., ALLANORE Y., LAUNAY D. et al. - Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study. J. Rheumatol., 2008 Jun., 35, 1064-72. (Pubitemid 351813153)
22. TYNDALL A., GRATWOHL A. - Immune ablation and stem-cell therapy in autoimmune disease: Clinical experience. Arthritis Res., 2000,2, 276-80. (Pubitemid 32223748)
23. FURST D., MCSWEENEY P., NASH R., HOLMBERG L., VIGANEGO F., NELSON I. et al. - High-dose immunosuppressive therapy (HDIT) with autologous stem cell transplantation (SCT) for systemic sclerosis (SSc): results on the first 8 patients. Arthr. Rheum., 2000,43, S392.
24. NADASHKEVICH O., DAVIS P., FRITZLER M., KOVALENKO W. - A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis. Clin. Rheumatol., 2006,25,205-12. (Pubitemid 43372319)
25. RACHU G., DEPASO W.J., CAIN K., HAMMAR S.P., WETZEL C.E., DREIS D.F. et al. - Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective doubleblind, randomized, placebo-controlled clinical trial. Am. Rev. Respir. Dis., 1991,144, 291-6.
26. RUBIN L.J., BADESCH D.B., BARST R.J., GALIE N., BLACK CM., KEOGHI A., PULIDO T., FROST A., Roux S., LECOMTE I., LANDZBERG M., SIMONNEAU G. - Bosentan therapy for pulmonary arterial hypertension. N. Engl. J. Med, 2002 Mar. 21,346(12), 896-903. (Pubitemid 34984638)
27. Erratum in: N. Engl. J. Med, 2002 Apr. IS, 346(16), 1258.
28. GALIE N., GHOFRANI H.A., TORBICKI A., BARST R.J., RUBIN L.J., BADESCH D., FLEMING T., PARPIA T., BURGESS G., BRANZI A., GRIMMINGER F., KURZYNA M., SIMONNEAU G. - Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group. Sildenafil citrate therapy for pulmonary arterial hypertension. N. Engl. J. Med., 2005 Nov 17., 353(20), 2148-57.
29. Erratum in: N. Engl. J. Med., 2006 Jun. 1,354(22), 2400-1.
30. GALIE N., RUBIN L.J., HORPER M., JANSA P., AL-HITI H., MEYER G., CHIOSSI E., KUSIC-PAJIC A., SIMONNEAU G. - Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet. 2008 Jun. 21,371, 2093-10.
31. LAUNAY D., BAUDET T., COTTENCIN O., BEREZNE A., ZEPHIR H., MORELL-DUBOIS S., PRUVO J.P., GUILLEVIN L., HATRON P.Y., HACHULLA E., MOUTHON L. - Manifestations psychiatriques de la sclerodermie systemique. Presse Med., 2010,39, 539-47.